Editas Medicine Names Jessica Hopfield, Ph.D., to Board of Directors – Markets Insider
Weekly RegisterEditas Medicine Names Jessica Hopfield, Ph.D., to Board of DirectorsMarkets InsiderAs a leading genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cpf1 genome editing s… Continue reading
